We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Syndecan-4 Functionalization Reduces the Thrombogenicity of Engineered Vascular Biomaterials.
- Authors
Wu, Yidi; Wagner, William D.
- Abstract
Blood–biomaterial compatibility is essential for tissue repair especially for endovascular biomaterials where small-diameter vessel patency and endothelium formation is crucial. To address this issue, a composite biomaterial termed PFC fabricated from poly (glycerol sebacate), silk fibroin, and collagen was used to determine if functionalization with syndecan-4 (SYN4) would reduce thrombogenesis through the action of heparan sulfate. The material termed, PFC_SYN4, has structure and composition similar to native arterial tissue and has been reported to facilitate the binding and differentiation of endothelial colony-forming cells (ECFCs). In this study, the hemocompatibility of PFC_SYN4 was evaluated and compared with non-functionalized PFC, electrospun collagen, ePTFE, and bovine pericardial patch (BPV). Ultrastructurally, platelets were less activated when cultured on PFC and PFC_SYN4 compared to collagen where extensive platelet degranulation was observed. Quantitatively, 31% and 44% fewer platelets adhered to PFC_SYN4 compared to non-functionalized PFC and collagen, respectively. Functionalization of PFC resulted in reduced levels of complement activation compared to PFC, collagen, and BPV. Whole blood clotting times indicated that PFC_SYN4 was less thrombogenic compared with PFC, collagen, and BPV. These results suggest that syndecan-4 functionalization of blood-contacting biomaterials provides a novel solution for generating a reduced thrombogenic surface.
- Subjects
BLOOD coagulation; HEPARAN sulfate; COMPLEMENT activation; SILK fibroin; ENDOTHELIAL cells
- Publication
Annals of Biomedical Engineering, 2024, Vol 52, Issue 7, p1873
- ISSN
0090-6964
- Publication type
Article
- DOI
10.1007/s10439-023-03199-w